Changeflow GovPing Healthcare & Life Sciences Patent Application for Inflammatory Condition T...
Routine Notice Added Draft

Patent Application for Inflammatory Condition Treatment Compositions

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

The USPTO has published a new patent application (US20260083701A1) for compositions and methods related to the treatment of inflammatory conditions. The application details compounds and formulations aimed at managing inflammation and associated symptoms like dryness, itching, and redness.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a published patent application from the USPTO detailing novel compositions, formulations, and methods for treating inflammatory conditions. The application, filed on September 26, 2025, and published on March 26, 2026, describes compounds designed to alleviate symptoms such as dryness, itching, redness, roughness, or flakiness of the skin associated with inflammatory disorders.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it represents potential future intellectual property that could impact drug development and market exclusivity in the pharmaceutical sector. Companies involved in the research and development of anti-inflammatory treatments should monitor this application and related patents for competitive intelligence and potential licensing opportunities.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

COMPOSITIONS, FORMULATIONS, AND METHODS FOR TREATMENT OF INFLAMMATORY CONDITIONS

Application US20260083701A1 Kind: A1 Mar 26, 2026

Inventors

Enzo Corey BENFANTI, Avinash BOPPANA, Kongyu ZHANG, Evan ZHAO, Connor Wilson COLEY

Abstract

Compounds and compositions for relief, management, or treatment of inflammation conditions, disorders, or diseases are provided herein. Methods for treatment of inflammatory conditions or disorders are also provided herein. The methods may reduce dryness, itching, redness, roughness, or flakiness of skin.

CPC Classifications

A61K 31/40 A61K 9/0014 A61K 9/06 A61K 31/4025 A61K 31/403 A61K 31/437 A61K 31/5025 A61K 31/5377 A61P 17/00

Filing Date

2025-09-26

Application No.

19341739

View original document →

Named provisions

Abstract Inventors CPC Classifications

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083701A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Inflammation Treatment
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Drug Development Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!